Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Matein Khalid Risk assets went ballistic this week as DonnyT did his tariff man war dance, hurled his Tomahawk at Canada, Mexico, China ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

With a slew of tech announcements dominating the headlines recently, it’s been easy to overlook some equally important ...

FDA finds benzene contamination, Tronox to close a pigment plant, Sofinnova launches a European biotech fund, and more ...

In a notable sell-off, ARK reduced its holdings in Illumina Inc (NASDAQ: ILMN ), offloading a total of 42,616 shares. While the specific dollar value of this transaction was not provided, it follows a ...